Modulation by melatonin of the cardiotoxic and antitumor activities of adriamycin.
Kim C, Kim N, Joo H, Youm JB, Park WS, Cuong DV, Park YS, Kim E, Min CK, Han J.
Kim C, et al. Among authors: park ws, park ys.
J Cardiovasc Pharmacol. 2005 Aug;46(2):200-10. doi: 10.1097/01.fjc.0000171750.97822.a2.
J Cardiovasc Pharmacol. 2005.
PMID: 16044032